Histopathological risk assessment in multisite epithelial dysplasia: A meta‐analysis
Oral Diseases · 2024
DOI: 10.1111/odi.15052 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Oral Diseases, 2024. Verfasst von Daniel Lobato Ferreira Ferraz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil. Hauptthemen laut MEDLINE: Mouth Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Objective
Histopathological grading of oral epithelial dysplasia (OED) is the current standard for stratifying cancer progression risk but is associated with subjectivity and variability. This problem is not commonly seen regarding the grading of epithelial dysplasia in other sites. This systematic review aims to compare grading systems for oral, anal, penile, and cervical epithelial dysplasia to determine their predictive accuracy for recurrence and malignant transformation (MT) outcomes.
Methods
The review protocol was registered in PROSPERO (CRD42023403035) and was reported according to the PRISMA checklist. A comprehensive search was performed in the main databases and gray literature. The risk of bias in individual studies was analyzed using the Joanna Briggs Institute checklist for each study design.
Results
Forty‐six studies were deemed eligible and included in this systematic review, of which 45 were included in the quantitative analysis. Meta‐analysis revealed that the binary system demonstrated a higher predictive ability for MT/recurrence of OED compared to multilevel systems. Higher predictive accuracy of MT was also observed for binary grading systems in anal intraepithelial neoplasia.
Conclusions
No significant difference was found between the current grading systems of epithelial dysplasia in different body parts. However, binary grading systems have shown better clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.
- Department of Stomatologic Sciences, School of Dentistry, Federal University of Goiás, Goiânia, Goiás, Brazil.
- UWA Dental School, The University of Western Australia, Nedlands, Western Australia, Australia.
- Oral Medicine and Pathology, Research Unit of Population Health, University of Oulu, Oulu, Finland.
- Medical Research Center and Oulu University Hospital, Oulu, Finland.
- Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
ORCID-Profile: Daniel Lobato Ferreira Ferraz, Erison Santana Dos Santos, Caique Mariano Pedroso, Brunno Santos de Freitas Silva, Omar Kujan, Tuula Anneli Salo, Mohammed I Malki, Susanna Juteau, Pablo Agustin Vargas, Marcio Ajudarte Lopes, Alan Roger Santos-Silva
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Ferraz, D. L. F., Dos Santos, E. S., Pedroso, C. M., Silva, B. S. F., Kujan, O., Salo, T. A., Malki, M. I., Juteau, S., Vargas, P. A., Lopes, M. A., & Santos-Silva, A. R. (2024). Histopathological risk assessment in multisite epithelial dysplasia: A meta‐analysis. Oral Diseases. https://doi.org/10.1111/odi.15052
Vancouver
Ferraz DLF, Dos Santos ES, Pedroso CM, Silva BSF, Kujan O, Salo TA, et al. Histopathological risk assessment in multisite epithelial dysplasia: A meta‐analysis. Oral Diseases. 2024. doi:10.1111/odi.15052
BibTeX
@article{Ferraz2024,
author = {Ferraz, Daniel Lobato Ferreira and Dos Santos, Erison Santana and Pedroso, Caique Mariano and Silva, Brunno Santos de Freitas and Kujan, Omar and Salo, Tuula Anneli and Malki, Mohammed I and Juteau, Susanna and Vargas, Pablo Agustin and Lopes, Marcio Ajudarte and Santos-Silva, Alan Roger},
title = {Histopathological risk assessment in multisite epithelial dysplasia: A meta‐analysis},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.15052}
}
EUVIMED